Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data
F Boscia, D Veritti, C Iaculli… - European Journal …, 2024 - journals.sagepub.com
The high prevalence of Diabetic macular edema (DME) is a real global health problem. Its
complex pathophysiology involves different pathways. Over the last decade, the introduction …
complex pathophysiology involves different pathways. Over the last decade, the introduction …
Optical coherence tomography biomarkers in predicting treatment outcomes of diabetic macular edema after dexamethasone implants
Purpose To identify optical coherence tomography (OCT) biomarkers that may predict
functional and anatomical outcomes in diabetic macular edema (DME) patients treated with …
functional and anatomical outcomes in diabetic macular edema (DME) patients treated with …
Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
JM Ruiz-Moreno, J Ruiz-Medrano - Graefe's Archive for Clinical and …, 2023 - Springer
Background To evaluate the cost-effectiveness of early-versus late-switch to the intravitreal-
dexamethasone implant (DEX-i) in patients with diabetic macular edema (DME) who did not …
dexamethasone implant (DEX-i) in patients with diabetic macular edema (DME) who did not …
Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
C Yanxia, Y Xiongyi, F Min, K Xiaoyun - Ophthalmic Research, 2024 - karger.com
Introduction: Objectives of the study were to investigate the correlation between optical
coherence tomography (OCT)-based grading of diabetic macular edema (DME) and …
coherence tomography (OCT)-based grading of diabetic macular edema (DME) and …
[HTML][HTML] Comparison of optical coherence tomography biomarkers between bevacizumab good responders and nonresponders who were switched to dexamethasone …
JH Lee, JY Shin, J Ahn - Korean journal of ophthalmology: KJO, 2023 - ncbi.nlm.nih.gov
Purpose To compare volumetric optical coherence tomography (OCT) biomarkers in
bevacizumab responsive and bevacizumab refractory diabetic macular edema (DME) …
bevacizumab responsive and bevacizumab refractory diabetic macular edema (DME) …
Anatomical and visual outcomes of Retreatment with Intravitreal Dexamethasone Implant versus shifting to intravitreal Aflibercept for refractory Diabetic macular …
WA Ewais, RM Sobhi, LS Aly - Egyptian Journal of Ophthalmology …, 2023 - journals.ekb.eg
Aim: to evaluate the anatomical and visual outcomes of retreatment with repeated intravitreal
dexamethasone implants versus repeated aflibercept injections for refractory diabetic …
dexamethasone implants versus repeated aflibercept injections for refractory diabetic …
When to Perform a Treatment Switch in Diabetic Macular Edema in Patients with Inadequate Response to Anti-VEGF
J Ruiz-Medrano, L Gonzalez-Buendia… - Medical Research …, 2022 - esmed.org
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients.
Multiple therapeutic options are currently available for these patients, including laser …
Multiple therapeutic options are currently available for these patients, including laser …